18 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

FLEX SPAN TEMPORARY CROWN & BRIDGE MATERIAL

FDA 510(k)
FDA Class 2 ·Dental

BUSCH®, BNA®

FDA UDI
BUSCH & CO. GmbH & Co. KG·D8120214571·Carbide, flame, fine finishing bur, yellow ring

SODEM HIGH SPEED SYSTEM (ELECTRIC) (NEURO/SPINE SURGERY)

FDA 510(k)
FDA Class 2 ·Neurology

ALOKA SSD-5500 WITH KI AND A-SMA

FDA 510(k)
FDA Class 2 ·Radiology

EXPRO ELITE SNARE

FDA Adverse Event
Injury ·VASCULAR SOLUTIONS, INC·Product code MMX·June 19, 2017

XPS® BUR - STYLUS TRANSNASAL

FDA Adverse Event
Malfunction ·MEDTRONIC XOMED INC.·Product code ERL·March 16, 2017

ARTICUL/EZE M 36MM +1.5

FDA Adverse Event
Injury ·8010379 DEPUY INTL., LTD.·Product code JDI·March 26, 2013

SECURE 2 MED/SURGBED

FDA Adverse Event
Malfunction ·STRYKER MEDICAL·Product code FNL·February 16, 2011

FREESTYLE

FDA Adverse Event
Malfunction ·ABBOTT DIABETES CARE INC, USA·Product code LFR·May 29, 2007

BD PRECISIONGLIDE¿ NEEDLE

FDA Adverse Event
Malfunction ·BD MEDICAL (BD WEST) MEDICAL SURGICAL·Product code FMI·April 8, 2021

NEEDLE 30X1/2 RB

FDA Adverse Event
Malfunction ·BD MEDICAL (BD WEST) MEDICAL SURGICAL·Product code FMI·June 29, 2021

BD PRECISIONGLIDE¿ NEEDLES

FDA Adverse Event
Malfunction ·BD MEDICAL (BD WEST) MEDICAL SURGICAL·Product code FMI·March 13, 2023

BD PRECISIONGLIDE¿ NEEDLES

FDA Adverse Event
Injury ·BD MEDICAL (BD WEST) MEDICAL SURGICAL·Product code FMI·May 31, 2023

NDLE 25GA 7/8IN ECG BLT NO-ANL TRANS ORN

FDA Adverse Event
Malfunction ·BD MEDICAL (BD WEST) MEDICAL SURGICAL·Product code FMI·February 18, 2019

BD PRECISIONGLIDE¿ NEEDLE

FDA Adverse Event
Malfunction ·BD MEDICAL (BD WEST) MEDICAL SURGICAL·Product code FMI·July 31, 2019

The Propaq LT Series monitors. Model numbers 802LTAN, 802LT0N, and 802LTRN. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medical-surgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. intended to be used by clinicians and medically qualified personnel for single or multiparameter vital signs monitoring of ambulatory and nonambulatory patients, including neonate, pediatric and adult patients. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medicalsurgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. The monitors can be used as stand-alone devices or as devices networked to an Acuity Central Station through wireless communication over a Welch Allyn FlexNet network.

FDA Enforcement
Class II ·Terminated·Welch Allyn Protocol, Inc·January 15, 2014

Ellipse Implantable Cardioverter Defibrillators (ICDs), Model No. CD1275, CD1311, CD2275, CD2311, CD1411, CD2411 Ellipse ST Implantable Cardioverter Defibrillators (ICDs), Model No. CD1273, CD1309, CD1409, CD2273, CD2309, CD2409.

FDA Enforcement
Class II ·Terminated·St Jude Medical Cardiac Rhythm Management Division·September 10, 2014

Ultraview SL Command Modules, Model 91496-M, upgraded with the Masimo SpO2 Option. Product Usage: The Spacelabs Multi-parameter Module is intended for use with the Patient Care Management System (PCMS) to acquire, monitor, and process various clinical parameters from an adult or neonate/infant populations in any type of clinical environment other than home use. Physiological parameters that may be monitored include ECG with arrhythmia detection, respiration, invasive and noninvasive blood pressure, temperature, oxygen saturation (Sp02) and cardiac output. Acquired data may then be communicated to all information network for display, recording, editing and analysis.

FDA Enforcement
Class II ·Terminated·Spacelabs Healthcare Inc·May 6, 2015